In a study published on Thursday (29 August), European and United States researchers tested an experimental vaccine against viruses and other bacteria that cause disease in infants and young children, known as age-related diseases.
Vaccines protected younger children and older adults from illness and they also showed “significantly longer” protective periods of protection against infection with different vaccine strains than a conventional regimen, they said.
For example, the version tested in the study had protection against tetanus in children aged 6 to 11 that was 88% longer than a conventional vaccination, they said.
“There are many diseases that are somewhat common in children, but that cause serious and even life-threatening complications, such as pneumonia,” said Michael Osterholm, a physician, researcher and director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota.
Because vaccines are so effective, vaccines also tend to work best on children and young adults.
So the results from this study are significant, Osterholm said in a statement.